STEMCELLRES . BIOMEDCENTRAL . COM {
}
Title:
Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials | Stem Cell Research & Therapy | Full Text
Description:
Chronic liver diseases, including cirrhosis and liver failure, remain formidable challenges due to their complex progression and limited therapeutic options. Mesenchymal stem cell (MSC) therapy has emerged as a game-changing approach, leveraging its potent immunomodulatory, anti-fibrotic, and regenerative capabilities, along with the ability to transdifferentiate into hepatocytes. This review delves into the latest advances in MSC-based treatments for chronic and end-stage liver diseases, as highlighted in current clinical trials. MSCs derived from bone marrow and umbilical cord have shown remarkable promise in reversing liver damage, improving liver function, and providing hope for patients who do not respond to conventional therapies. When administered through hepatic, portal, or peripheral veins, MSCs have significantly improved liver histology, reduced fibrosis, and restored functional capacity. Furthermore, MSC-derived materials, such as extracellular vesicles and exosomes, are emerging as cutting-edge tools for treating liver failure and mitigating post-transplant complications. While autologous MSC-derived hepatocytes hold promise for non-fatal cirrhosis, allogeneic MSCs are being applied in more severe conditions, including liver failure and transplantation cases. Despite these promising early outcomes, larger trials and long-term studies are essential to fully harness MSCs as a transformative, off-the-shelf alternative to liver transplantation, heralding a new era in regenerative liver therapies.
Website Age:
25 years and 10 months (reg. 1999-08-06).
Matching Content Categories {📚}
- Social Networks
- Telecommunications
- Non-Profit & Charity
Content Management System {📝}
What CMS is stemcellres.biomedcentral.com built with?
Custom-built
No common CMS systems were detected on Stemcellres.biomedcentral.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of stemcellres.biomedcentral.com audience?
🚀 Good Traffic: 50k - 100k visitors per month
Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Stemcellres.biomedcentral.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (3)
yourbow.com, google.com, doceree.comHow Much Does Stemcellres.biomedcentral.com Make? {💰}
Display Ads {🎯}
$690 per month
Estimations show Stemcellres.biomedcentral.com's display ad online revenue falls between $462 and $1,271 per month.
Keywords {🔍}
cookies, bmc, privacy, clinical, page, data, stem, cell, therapy, liver, trials, contact, optional, content, personal, parties, policy, information, manage, research, submission, diseases, conditions, website, article, enquiries, editing, authors, choice, essential, make, site, function, advertising, personalisation, usage, analysis, social, media, accepting, consent, processing, including, transfers, european, economic, area, varying, standards, protection,
Topics {✒️}
authors scientific editing privacy choices/manage cookies bmc european economic area state privacy rights accepting optional cookies click contact manage preferences clinical trials 1757-6512 contact submission enquiries personal data optional cookies data protection essential cookies cookies skip cookies policy privacy policy privacy statement usage analysis social media varying standards game-changer liver diseases human mscs general enquiries preference centre springer nature content liver conditions choices website privacy conditions choice make site function advertising personalisation consent processing parties information change accept published review number retrieved
Schema {🗺️}
WebPage:
mainEntity:
headline:Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
description:Chronic liver diseases, including cirrhosis and liver failure, remain formidable challenges due to their complex progression and limited therapeutic options. Mesenchymal stem cell (MSC) therapy has emerged as a game-changing approach, leveraging its potent immunomodulatory, anti-fibrotic, and regenerative capabilities, along with the ability to transdifferentiate into hepatocytes. This review delves into the latest advances in MSC-based treatments for chronic and end-stage liver diseases, as highlighted in current clinical trials. MSCs derived from bone marrow and umbilical cord have shown remarkable promise in reversing liver damage, improving liver function, and providing hope for patients who do not respond to conventional therapies. When administered through hepatic, portal, or peripheral veins, MSCs have significantly improved liver histology, reduced fibrosis, and restored functional capacity. Furthermore, MSC-derived materials, such as extracellular vesicles and exosomes, are emerging as cutting-edge tools for treating liver failure and mitigating post-transplant complications. While autologous MSC-derived hepatocytes hold promise for non-fatal cirrhosis, allogeneic MSCs are being applied in more severe conditions, including liver failure and transplantation cases. Despite these promising early outcomes, larger trials and long-term studies are essential to fully harness MSCs as a transformative, off-the-shelf alternative to liver transplantation, heralding a new era in regenerative liver therapies.
datePublished:2025-01-06T00:00:00Z
dateModified:2025-01-06T00:00:00Z
pageStart:1
pageEnd:17
license:http://creativecommons.org/licenses/by-nc-nd/4.0/
sameAs:https://doi.org/10.1186/s13287-024-04127-y
keywords:
Mesenchymal stem cells (MSCs)
Immunomodulation
Anti-fibrosis
Transdifferentiation
Liver cirrhosis
End-stage liver diseases
Stem Cells
Cell Biology
Regenerative Medicine/Tissue Engineering
Biomedical Engineering and Bioengineering
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-024-04127-y/MediaObjects/13287_2024_4127_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-024-04127-y/MediaObjects/13287_2024_4127_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-024-04127-y/MediaObjects/13287_2024_4127_Fig3_HTML.png
isPartOf:
name:Stem Cell Research & Therapy
issn:
1757-6512
volumeNumber:16
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Wei-Chen Huang
affiliation:
name:National Defense Medical Center
address:
name:Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
type:PostalAddress
type:Organization
name:National Defense Medical Center
address:
name:Laboratory of Clinical Immunology, National Defense Medical Center, Taipei, Taiwan
type:PostalAddress
type:Organization
type:Person
name:Yuan-Chi Li
affiliation:
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
type:Person
name:Pin-Xuan Chen
affiliation:
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
type:Person
name:Kevin Sheng-Kai Ma
affiliation:
name:University of Pennsylvania
address:
name:Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Li-Tzu Wang
affiliation:
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
name:Taipei Medical University
address:
name:Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
description:Chronic liver diseases, including cirrhosis and liver failure, remain formidable challenges due to their complex progression and limited therapeutic options. Mesenchymal stem cell (MSC) therapy has emerged as a game-changing approach, leveraging its potent immunomodulatory, anti-fibrotic, and regenerative capabilities, along with the ability to transdifferentiate into hepatocytes. This review delves into the latest advances in MSC-based treatments for chronic and end-stage liver diseases, as highlighted in current clinical trials. MSCs derived from bone marrow and umbilical cord have shown remarkable promise in reversing liver damage, improving liver function, and providing hope for patients who do not respond to conventional therapies. When administered through hepatic, portal, or peripheral veins, MSCs have significantly improved liver histology, reduced fibrosis, and restored functional capacity. Furthermore, MSC-derived materials, such as extracellular vesicles and exosomes, are emerging as cutting-edge tools for treating liver failure and mitigating post-transplant complications. While autologous MSC-derived hepatocytes hold promise for non-fatal cirrhosis, allogeneic MSCs are being applied in more severe conditions, including liver failure and transplantation cases. Despite these promising early outcomes, larger trials and long-term studies are essential to fully harness MSCs as a transformative, off-the-shelf alternative to liver transplantation, heralding a new era in regenerative liver therapies.
datePublished:2025-01-06T00:00:00Z
dateModified:2025-01-06T00:00:00Z
pageStart:1
pageEnd:17
license:http://creativecommons.org/licenses/by-nc-nd/4.0/
sameAs:https://doi.org/10.1186/s13287-024-04127-y
keywords:
Mesenchymal stem cells (MSCs)
Immunomodulation
Anti-fibrosis
Transdifferentiation
Liver cirrhosis
End-stage liver diseases
Stem Cells
Cell Biology
Regenerative Medicine/Tissue Engineering
Biomedical Engineering and Bioengineering
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-024-04127-y/MediaObjects/13287_2024_4127_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-024-04127-y/MediaObjects/13287_2024_4127_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-024-04127-y/MediaObjects/13287_2024_4127_Fig3_HTML.png
isPartOf:
name:Stem Cell Research & Therapy
issn:
1757-6512
volumeNumber:16
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Wei-Chen Huang
affiliation:
name:National Defense Medical Center
address:
name:Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
type:PostalAddress
type:Organization
name:National Defense Medical Center
address:
name:Laboratory of Clinical Immunology, National Defense Medical Center, Taipei, Taiwan
type:PostalAddress
type:Organization
type:Person
name:Yuan-Chi Li
affiliation:
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
type:Person
name:Pin-Xuan Chen
affiliation:
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
type:Person
name:Kevin Sheng-Kai Ma
affiliation:
name:University of Pennsylvania
address:
name:Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Li-Tzu Wang
affiliation:
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
name:Taipei Medical University
address:
name:Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Stem Cell Research & Therapy
issn:
1757-6512
volumeNumber:16
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:National Defense Medical Center
address:
name:Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
type:PostalAddress
name:National Defense Medical Center
address:
name:Laboratory of Clinical Immunology, National Defense Medical Center, Taipei, Taiwan
type:PostalAddress
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
name:University of Pennsylvania
address:
name:Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
name:Taipei Medical University
address:
name:Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Wei-Chen Huang
affiliation:
name:National Defense Medical Center
address:
name:Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
type:PostalAddress
type:Organization
name:National Defense Medical Center
address:
name:Laboratory of Clinical Immunology, National Defense Medical Center, Taipei, Taiwan
type:PostalAddress
type:Organization
name:Yuan-Chi Li
affiliation:
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
name:Pin-Xuan Chen
affiliation:
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
name:Kevin Sheng-Kai Ma
affiliation:
name:University of Pennsylvania
address:
name:Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Li-Tzu Wang
affiliation:
name:Taipei Medical University
address:
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
name:Taipei Medical University
address:
name:Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
name:Laboratory of Clinical Immunology, National Defense Medical Center, Taipei, Taiwan
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
name:Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
name:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
name:Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
External Links {🔗}(23)
- How much money does https://www.biomedcentral.com/privacy-statement generate?
- How much cash flow does https://www.biomedcentral.com have monthly?
- How much does https://www.biomedcentral.com/journals pull in?
- How much does https://www.biomedcentral.com/getpublished net monthly?
- What's the financial outcome of https://www.biomedcentral.com/about?
- How much does https://www.biomedcentral.com/account earn?
- What is the earnings of https://submission.springernature.com/new-submission/13287/3?
- What's the income generated by https://ClinicalTrials.gov/ each month?
- How much money does https://www.editorialmanager.com/scrt generate?
- How much does https://blogs.biomedcentral.com/ gross monthly?
- Learn about the earnings of https://www.biomedcentral.com/login
- Earnings of https://authorservices.springernature.com/go/sn/?utm_source=Website&utm_medium=BMC&utm_campaign=SNAS+Referrals+2022&utm_id=ref2022
- Financial intake of https://www.biomedcentral.com/about/policies
- What's https://www.biomedcentral.com/accessibility's gross income?
- Explore the financials of https://www.biomedcentral.com/about/press-centre
- What's the financial outcome of https://support.biomedcentral.com/support/home?
- How much does https://biomedcentral.typeform.com/to/VLXboo pull in?
- See how much https://www.biomedcentral.com/about/jobs makes per month
- Find out how much http://www.weibo.com/biomedcentral earns monthly
- How much revenue does https://www.biomedcentral.com/terms-and-conditions produce monthly?
- How much does https://www.springernature.com/ccpa gross monthly?
- How much cash flow does https://www.biomedcentral.com/cookies have monthly?
- How much revenue does https://www.springernature.com produce monthly?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js